James Warren Huff, Chief Executive Officer at REATA PHARMACEUTICALS INC (RETA), sold 98,344 shares at $175.00 ($17.2M) on 2020-11-10, disclosed to the SEC on 2020-11-10.
Open-market sale of $17.2M RETA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $175.06 | 16,687 | $2.9M | 17.0% |
| 2 | $175.06 | 16,687 | $2.9M | 17.0% |
| 3 | $175.00 | 64,970 | $11.4M | 66.1% |
| Total | $175.02 avg | 98,344 | $17.2M | 100% |
| Filing → |
| RETA | BUY | 2016-06-02 | $1.3M | — | Filing → |